Focus Partners Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Focus Partners Wealth's JAZZ Position: Q3 2026 in Review
Focus Partners Wealth increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q3 2026, buying an estimated $1.17M and bringing the position to 24,596 shares worth $5.69M. The position accounts for 0.01% of the portfolio, ranked #935.
Focus Partners Wealth first reported a position in JAZZ in Q1 2024 and has held it in 10 quarters since. 559 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Focus Partners Wealth held 24,596 shares of Jazz Pharmaceuticals worth $5.69M as of Q3 2026.
- Focus Partners Wealth bought 4,754 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.17M.
- Jazz Pharmaceuticals made up 0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #935 holding.
- Focus Partners Wealth first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- 559 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.